| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,582,000 | 8,490,000 | 7,883,000 | 6,569,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 8,490,000 | 7,883,000 | 6,569,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,948,000 | 7,251,000 | 5,908,000 | 6,620,000 | | Non Recurring | 39,000 | 28,000 | 45,000 | 19,000 | | Others | 1,023,000 | 1,229,000 | 1,397,000 | 1,665,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 34,000 | (18,000) | 533,000 | (1,735,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (3,000) | 3,000 |
-
| | Earnings Before Interest And Taxes | 331,000 | (21,000) | 536,000 | (1,735,000) | | Interest Expense | 106,000 | (482,000) | 667,000 | 87,000 | | Income Before Tax | 225,000 | 461,000 | (131,000) | (1,822,000) | | Income Tax Expense | 4,000 | 72,000 | 143,000 | (693,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 221,000 | 389,000 | (274,000) | (1,129,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 221,000 | 389,000 | (274,000) | (1,129,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $221,000 | $389,000 | ($274,000) | ($1,129,000) |
|
0.01% Nasdaq 0.00%
Income Statement
